Financings In Brief
This article was originally published in The Gray Sheet
Executive Summary
MicroChips, Inc.: Recently completed $16 mil. private placement will accelerate development of the Cambridge, Massachusetts-based firm's "intelligent" drug delivery system and anticipated clinical trials. The implantable device employs MEMS (micro-electromechanical systems) technology and wireless communications to deliver accurate doses of medication. MicroChips expects to use the technology for applications in pain management, hormone and steroid delivery, and certain cancer and central nervous system (CNS) disorders. New investor IDG Ventures led the round...
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.